{"id":124851,"date":"2015-07-23T14:58:34","date_gmt":"2015-07-23T14:58:34","guid":{"rendered":"https:\/\/bm.dev.synology.me\/?p=124851"},"modified":"2015-07-23T14:58:34","modified_gmt":"2015-07-23T14:58:34","slug":"crestere-cu-6-a-vanzarilor-grupului-roche-in-prima-jumatate-a-anului-2015","status":"publish","type":"post","link":"https:\/\/bm.dev.synology.me\/?p=124851","title":{"rendered":"Cre\u015ftere cu 6% a v\u00e2nz\u0103rilor Grupului Roche \u00een prima jum\u0103tate a anului 2015"},"content":{"rendered":"<p>\nDivizia de Diagnostic a \u00eenregistrat, de asemenea, cre\u015fteri semnificative \u00een special datorit\u0103 testelor de imunologie \u015fi produselor de diagnostic molecular.<\/p>\n<p>\nV\u00e2nz\u0103rile Diviziei de Farmaceutice a Roche au crescut cu 5% \u00een primele \u015fase luni ale anului 2015, la o rat\u0103 de schimb constant\u0103, ajung\u00e2nd&nbsp; la 18.350 miloane de franci elve\u0163ieni. Aceast\u0103 cre\u015ftere s-a datorat \u00een special francizei de medicamente pentru tratamentul cancerului de s\u00e2n HER2 pozitiv \u2013 cre\u015ftere de 21%, mai mare cu un procent fa\u0163\u0103 de anul trecut &#8211; \u015fi a v\u00e2nz\u0103rilor medicamentelor pentru astm, artrit\u0103 reumatoid\u0103 \u015fi pentru hematologie. V\u00e2nz\u0103rile au \u00eenregistrat o cre\u015ftere de 7% \u00een Statele Unite, de 7% \u00een Japonia \u015fi de 2% \u00een Europa.<\/p>\n<p>\nDivizia de Diagnostic a \u00eenregistrat v\u00e2nz\u0103ri \u00een cre\u015ftere cu 7% \u00een prima jum\u0103tate a anului, ridic\u00e2ndu-se la 5.235 milioane de franci elve\u0163ieni, \u00een principal datorit\u0103 cererii sus\u0163inute pentru produsele de diagnostic imunologic. V\u00e2nz\u0103rile Diabetes Care au crescut cu 1%, \u00een timp ce Molecular Diagnostic \u015fi Tissue Diagnostic au \u00eenregistrat cre\u015fteri de 12% fiecare.<br \/>\nEstim\u0103ri pentru anul 2015<\/p>\n<p>\nPentru anul 2015, Grupul Roche estimeaz\u0103 o cre\u015ftere a v\u00e2nz\u0103rilor cu o singur\u0103 cifr\u0103, la o rat\u0103 de schimb constant\u0103, precum \u015fi o cre\u015ftere a dividendelor \u00een franci elve\u0163ieni.&nbsp;<\/p>\n<p>\nAv\u00e2nd sediul central \u00een Basel, Elve\u0163ia, compania Roche este unul dintre liderii mondiali ai industriei farmaceutice \u015fi de diagnostic, bazat\u0103 pe cercetare, prin sinergia oferit\u0103 de cele dou\u0103 divizii ale sale: Divizia de Farmaceutice \u015fi Divizia de Diagnostic.<\/p>\n<p>\n\u00cen 2014, Roche avea, la nivel global, peste 88.500 de angaja\u0163i, a investit 8,9 miliarde de franci elve\u0163ieni \u00een cercetare \u015fi dezvoltare si a raportat v\u00e2nz\u0103ri de 47,5 miliarde de franci elve\u0163ieni. Compania Genentech, din Statele Unite, este de\u0163inut\u0103 \u00een totalitate de grupul Roche.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Grupul farmaceutic elve\u0163ian Roche anun\u0163\u0103 o cre\u015ftere a v\u00e2nz\u0103rilor globale \u00een prima jum\u0103tate a anului 2015, cu 6%, la o rat\u0103 de schimb constant\u0103, ajung\u00e2nd la 23.585 milioane de franci elve\u0163ieni, \u00een special datorit\u0103 cererii crescute pentru medicamentele destinate tratamentului cancerului \u015fi bolilor autoimune.<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[510],"tags":[16199,13292,14610,8866,9321,10006,246,12922,7553,30466,467,22346,323,161,7541,9980,11528,8988,7134,12923,7212],"class_list":["post-124851","post","type-post","status-publish","format-standard","hentry","category-actualitate","tag-anunt","tag-boli","tag-cancer","tag-cercetare","tag-cerere","tag-constanta","tag-crestere","tag-diagnostic","tag-elvetia","tag-elvetieni","tag-grup","tag-inregistrare","tag-medicamente","tag-miliarde","tag-produse","tag-rata","tag-schimb","tag-special","tag-statele-unite","tag-tratament","tag-vanzari"],"_links":{"self":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts\/124851","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=124851"}],"version-history":[{"count":0,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts\/124851\/revisions"}],"wp:attachment":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=124851"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=124851"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=124851"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}